AI-Designed Synthetic CRISPR-like Nucleases Show Activity in Cells

Researchers have successfully used artificial intelligence to design synthetic proteins capable of gene editing, mirroring the functionality of CRISPR systems. By bypassing the limitations of naturally occurring enzymes, these engineered nucleases provide scientists with more customizable tools for precise genomic modifications in human cells.